'AQURO', a new, potentially automatable approach for quatifying mitral regurgitation: technology development and validation through collaboration between cardiovascular science and bioengineering
Completed
- Conditions
- Topic: Diabetes Research NetworkSubtopic: Type 2Disease: Cardiovascular diseaseCirculatory SystemMitral regurgitation
- Registration Number
- ISRCTN14627513
- Lead Sponsor
- Imperial College Healthcare NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Stable subjects with mitral regurgitation previously diagnosed on echocardiography
Exclusion Criteria
1. Atrial fibrillation
2. Moderate or severe disease of tricuspid or pulmonary valves
3. Any aortic valve disease graded mild or higher
4. Prosthetic aortic valve and body habitus or coexistent disease that precludes satisfactory imaging quality
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effective regurgitant orifice area (EROA), measured during 40 minutes of acquisition
- Secondary Outcome Measures
Name Time Method ot provided at time of registration